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API Decadic Dose of PAC Cost: 25 kr/kg 
Diclofenac 3.5 g/m3 0.088 kr/m3 
Ethinylestradiol 1 g/m3 0.025 kr/m3 
Ibuprofen <50 mg/m3 <0.001 kr/m3 
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 API 
Decadic Dose of ClO2 
(g/m
3
) 
Cost: 50 kr/kg 
Low COD High COD Low COD High COD 
Diclofenac 1 2.5 0.05 kr/m
3
 0.13 kr/m
3
 
Ethinylestradiol 1 2.5 0.05 kr/m3 0.13 kr/m3 
Ibuprofen >20 >20 >1.0 kr/m3 >1.0 kr/m3 
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API 
Decadic Dose of O3 
(g/m
3
) 
Cost: 20 kr/kg 
Low COD High COD Low COD High COD 
Diclofenac 4.5 11 0.09 kr/m
3
 0.22 kr/m
3
 
Ethinylestradiol 2 5 0.04 kr/m3 0.10 kr/m3 
Ibuprofen 9 10 0.18 kr/m
3
 0.20 kr/m
3
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EXECUTIVE SUMMARY 
The presence of active pharmaceutical ingredients (APIs) in municipal wastewater treatment 
plants (WWTPs) is considered to be the main source of contamination of water resources. 
The potential side effects that APIs can cause to wild life and humans from chronic exposure, 
necessitates their efficient removal from wastewater effluents prior discharge. The emerging 
solution to this problem for the environment is to implement an advanced targeted treatment 
for micropollutants at WWTPs. The most promising solutions in terms of effectiveness and 
economy are oxidation method, particularly ozone and chlor dioxide, and use of sorbents, 
particularly powder activated carbon.  Each treatment has different effectiveness for each 
API so it is not directly possible to select one optimal method for all APIs and therefore in 
practice the choice of method will depend on the list of prioritised chemicals which it is 
required to remove.   
In our comparison procedure we first consider the removal of each 
APIs by biodegradation that can be expected based on the 
treatment insensitivity and removal by sorption to sludge. 
Our concept of comparing the effect of different advanced 
treatments is to model, based on experimental data from laboratory 
scale studies, the treatment dose which removed 90 % of the 
concentration of each API. We have named this parameter: 
Decadic removal Dose, DD. Since most of the applied treatment 
chemical or sorbent is 
wasted on the bulk organic 
carbon in the wastewater 
and only a small fraction 
actually reacts with API, this 
concept is almost 
independent of the API 
concentration.  
In the Mistrapharma project 
decadic doses (g/m3 per 
1.st order of API removal) 
were determined for 50-75 
commonly occurring APIs in 
wastewater effluents for 
alternative polishing methods. 
Depending on the biological treatment and the APIs selected to be critical, each type of the 
additional treatments considered can be the best choice. 
